NCT07176728View on ClinicalTrials.gov

A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.

PHASE1RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 22, 2025

Primary Completion Date

January 30, 2026

Study Completion Date

January 30, 2026

Conditions
Sepsis Associated Disseminated Intravascular Coagulation (DIC)
Interventions
DRUG

BAY 3389934

Solution for intravenous infusion

DRUG

Matching Placebo / Diluent

Solution for intravenous infusion

Trial Locations (1)

813-0017

RECRUITING

SOUSEIKAI Fukuoka Mirai Hospital, Fukuoka

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT07176728 - A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers. | Biotech Hunter | Biotech Hunter